WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc., a global leader focused on the health and safety of people and their environment, today announced the extension of a research collaboration between its ViaCord Research Institute™ (VRI™) and The University of Texas M.D. Anderson Cancer Center. The collaboration underscores VRI’s commitment to advancing technologies that multiply cord blood stem cells, with the goal of treating more diseases and more adults.